{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]
RxNorm concept 2475418, branded pack (bpck). Prescribable name: CABENUVA 400 MG / 600 MG Extended Release Kit.
- RxCUI
- 2475418
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2475418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
CABENUVA 400 MG / 600 MG Extended Release Kit
Related concepts
- 2 ML cabotegravir 200 MG/ML Injection (SCD, contains)
- 2 ML rilpivirine 300 MG/ML Injection (SCD, contains)
- Pack (DF, has dose form)
- {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack (GPCK, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2475418 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2475418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2475418. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.